BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 20118800)

  • 1. A new model of chronic hapten-induced colitis in young rats.
    Fitzpatrick LR; Meirelles K; Small JS; Puleo FJ; Koltun WA; Cooney RN
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):240-50. PubMed ID: 20118800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
    Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
    Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acutely administered melatonin is beneficial while chronic melatonin treatment aggravates the evolution of TNBS-induced colitis.
    Marquez E; Sánchez-Fidalgo S; Calvo JR; la de Lastra CA; Motilva V
    J Pineal Res; 2006 Jan; 40(1):48-55. PubMed ID: 16313498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis.
    Peterson TC; Peterson MR; Raoul JM
    Eur J Pharmacol; 2011 Jul; 662(1-3):47-54. PubMed ID: 21554874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis.
    Eliakim R; Karmeli F; Rachmilewitz D; Cohen P; Fich A
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1013-9. PubMed ID: 9895047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
    Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.
    Santos FA; Silva RM; Campos AR; De Araújo RP; Lima Júnior RC; Rao VS
    Food Chem Toxicol; 2004 Apr; 42(4):579-84. PubMed ID: 15019181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model.
    da Silva MS; Sánchez-Fidalgo S; Talero E; Cárdeno A; da Silva MA; Villegas W; Souza Brito AR; de La Lastra CA
    J Ethnopharmacol; 2010 Mar; 128(2):467-75. PubMed ID: 20083187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action.
    Fitzpatrick LR; Small JS; Doblhofer R; Ammendola A
    J Pharmacol Exp Ther; 2012 Sep; 342(3):850-60. PubMed ID: 22691298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
    Zuo L; Huang Z; Dong L; Xu L; Zhu Y; Zeng K; Zhang C; Chen J; Zhang J
    Gut; 2010 Apr; 59(4):470-9. PubMed ID: 19951904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A receptors and uric acid mediate protective effects of inosine against TNBS-induced colitis in rats.
    Rahimian R; Fakhfouri G; Daneshmand A; Mohammadi H; Bahremand A; Rasouli MR; Mousavizadeh K; Dehpour AR
    Eur J Pharmacol; 2010 Dec; 649(1-3):376-81. PubMed ID: 20868668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.
    Fichtner-Feigl S; Young CA; Kitani A; Geissler EK; Schlitt HJ; Strober W
    Gastroenterology; 2008 Dec; 135(6):2003-13, 2013.e1-7. PubMed ID: 18938165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term study of TNBS-induced colitis in rats: focus on mast cells.
    Menozzi A; Pozzoli C; Poli E; Lazzaretti M; Grandi D; Coruzzi G
    Inflamm Res; 2006 Oct; 55(10):416-22. PubMed ID: 17109068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model.
    Adam B; Liebregts T; Gschossmann JM; Krippner C; Scholl F; Ruwe M; Holtmann G
    Pain; 2006 Jul; 123(1-2):179-86. PubMed ID: 16630696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J; Zheng C; Huang Y; Liang Y
    Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators.
    Abdolghaffari AH; Baghaei A; Moayer F; Esmaily H; Baeeri M; Monsef-Esfahani HR; Hajiaghaee R; Abdollahi M
    Hum Exp Toxicol; 2010 Apr; 29(4):287-95. PubMed ID: 20144954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.